Finance Score: -7

Governance Score: 3

Support Score: 2

Good reserves management: +3
Accounts overdue -5
Multiple Deficits and declines: -5

Dynamic board: +3
Gender balanced board: +3
Return overdue: -3

Grant maker support: +2

Overall GiG Score: -2

NATIONAL CANCER RESEARCH INSTITUTE

The advancement of health, in particular to promote and protect the health of the public by coordinating research into the causes, prevention, treatment and cure of all forms of cancer and into the needs of people affected by cancer. And to promote collaboration between cancer research funders in the UK to maximise the value and benefits of cancer research for the benefit of the public.

Analysis by Giving is Great

Positives:

The charity has received modest backing from a grant maker
Reserves management has been consistently within official guidelines
The Board appears to be well diversified in terms of gender and dynamic in terms of composition

Regulatory & Governance issues to consider:

This charity is not recognised by HMRC for Gift Aid according to its latest published return
Latest return is overdue

Financial issues to consider:

Latest accounts are overdue for filing
Income has been volatile and on several occasions in recent years less than spending

Financial Data ?

Income & Spending ?

Sources of Income ?

Y/E		Income £k	Spending £k	Surplus/ Deficit	Fundraising Cost £k	Total Funds £k	Unrestricted Funds £k	Mths Rsrvs	Staff
31/03/22		£1,578	£1,773	£-194	£0	£1,119	£971	6.6	26
31/03/21		£1,522	£1,845	£-324	£0	£1,199	£825	5.4	26
31/03/20		£2,598	£2,616	£-17	£0	£1,522	£1,175	5.4	24
31/03/19		£2,850	£2,527	£323	£0	£1,540	£1,199	5.7	25
31/03/18		£2,562	£2,800	£-238	£0	£1,217	£891	3.8	25
31/03/17		£4,006	£2,551	£1,455	£0	£1,455	£796	3.7	28
31/03/16	*	£0	£0	£0	n/a	n/a	n/a	n/a	n/a

Show more rows -->

Show financials table -->

Download accounts

Financial Ratios

Fundraising Costs/Relevant Income: 0%
Fundraising Costs/Total Spending: 0%
Senior Staff Costs/Total Spending: 26%
Highest pay band: £90,000-£100,000
Liabilities/Assets: 32%
Liabilities/Income: 34%
Unrestricted Funds/Total Funds: 87%
Reserves/Spending: 6.6 months
Net Current Assets/Spending: 8 months
Quick Ratio: 2.7

Asset Split ?

Established: 9 years

www.ncri.org.uk

info@ncri.org.uk

02034698798

Charity Commission for England and Wales

Tweets

Listed activities

The Advancement Of Health Or Saving Of Lives

GiG Classification

Medical research

How it operates

Acts as an umbrella or resource body
Provides advocacy/advice/information
Provides services

Where it operates

Northern Ireland, Scotland, Throughout England And Wales,

Who it helps

Other Charities Or Voluntary Bodies
The General Public/Mankind

Who supports them? ?

Donations from Grant Makers ?

We have details on the following significant donations. Multi-year donations are allocated to the years for which they are earmarked.

Specific Donations

Amount	When Months	To be used for
DCMS - 2019 NCRI Cancer Conference
£19,600	04/11/2019	To support an international marketing campaign to increase the number of international delegates attending an event

Data sourced from Donors via 360 Giving

How is it governed?

Trustees (7)

Current Trustees appointed

Gender Split

Age Range of Trustees:

CATHERINE SCIVIER Appointed: 2016, Occupation: Trustee, Other trusteeship: N-COMPASS TOWARDS A BRIGHTER FUTURE LIMITED,

CAMERON MILLAR Appointed: 2021

DR ANGUS GREGOR KEITH MCNAIR Appointed: 2016

DR IAN WALKER Appointed: 2021, Occupation: Director

DR MATTHEW DAVID HOBBS Appointed: 2018

FIONA DRISCOLL (Chair) Appointed: 2021

HELEN ROWNTREE Appointed: 2021

Legal constitution

Charity registered in England & Wales on 23/02/2015, number: 1160609

Gift Aid

NOT registered with HMRC for Gift Aid

Policies in force

Complaints handling
Conflicting interests
Paying staff
Risk management

Filing Record

7 returns made; AR16: 2 days late,

Main office

NCRI
2 Redman Place
London
E20 1JQ

Objectives

THE OBJECTS OF THE CIO ARE(1) THE ADVANCEMENT OF HEALTH, IN PARTICULAR TO PROMOTE AND PROTECT THE HEALTH OF THE PUBLIC BY CO-ORDINATING RESEARCH INTO THE CAUSES, PREVENTION, TREATMENT AND CURE OF ALL FORMS OF CANCER AND INTO THE NEEDS OF PEOPLE AFFECTED BY CANCER; AND(2) TO PROMOTE COLLABORATION BETWEEN CANCER RESEARCH FUNDERS IN THE UNITED KINGDOM TO MAXIMISE THE VALUE AND BENEFITS OF CANCER RESEARCH FOR THE BENEFIT OF THE PUBLIC; NOTHING IN THIS CONSTITUTION SHALL AUTHORISE AN APPLICATION OF THE PROPERTY OF THE CIO FOR THE PURPOSES WHICH ARE NOT CHARITABLE IN ACCORDANCE WITH SECTION 7 OF THE CHARITIES AND TRUSTEE INVESTMENT (SCOTLAND) ACT 2005 AND SECTION 2 OF THE CHARITIES ACT (NORTHERN IRELAND) 2008

Data Sources